When COVID Drug Studies End Up in EMF Research: A Database Reality Check

What happens when a COVID-19 antiviral drug trial gets misclassified as electromagnetic field research? This episode explores a fascinating case study in research database accuracy. I examine how the RECOVERY trial -- which tested molnupiravir and nirmatrelvir-ritonavir in over one thousand COVID patients -- somehow ended up categorized as EMF research. This mix-up reveals important lessons about research integrity, database management, and why careful verification matters in health science. In This Episode The RECOVERY trial's actual findings on COVID antivirals How research databases can go wrong Why proper study categorization matters for health research Featured Study Read the full study: From subsea power cable to small-spotted catshark Scyliorhinus canicula: Behavioural effects of electromagnetic fields in tank experiments See all studies at shieldyourbody.com/research